Barrett Esophagus Market Overview

An overview of conceptual frameworks, analytical approaches of the barrett esophagus market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Barrett esophagus market is expected to grow with significant rate in the near future.

The global barrett esophagus market in 2020 is accounted for more than US$ xx Mn and expected to reach a value of US$ xx Mn by 2028 with a significant CAGR of 4.1%.

MMC Overview

The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

Barrett Esophagus Market Definition

Barrett’s esophagus is a disorder, also known as Barrett's syndrome or columnar epithelium lined lower esophagus, in which there is an unusual variation in the interior lining of oesophagus (lower portion). The stomach cells (goblet cells) take the place of the cells of the esophagus (stratified squamous). This replacement of cells occurs due to the activity of stomach acids (chronic acids). The stomach acids are likely to leak into the food pipe or esophagus, if the enclosure of muscles at the lower part of oesophagus does not close firmly, which may cause harm to the esophageal cells over time and may result in Barrett’s esophagus.

The common signs and symptoms of Barrett Esophagus are similar to that of Gastroesophageal reflux disease (GERD) that is dysphagia, heartburn, sensation of a lump in the throat, acid reflux, dry cough, and chest pain. Generally this disease is diagnosed with the help of biopsy and endoscopy. Once the disease is diagnosed, patients are prescribed for the intake of acid-suppressing medications, also known as proton pump inhibitors.

There are different acid-suppressing medications patients could intake including pantoprazole, omeprazole, lansoprazole, esomeprazole, and rabeprazole. The medical care of Barrett Esophagus may also involve surgeries that include ablative therapies (radiofrequency ablation, photodynamic therapy), mucosal resection and esophagectomy. The patients are also usually advised to make dietary changes to reduce the risk of Barrett’s esophagus. This can be achieved by escalating the intake of vitamins, vegetables, and fruits.

Barrett Esophagus Market Dynamics

The growing prevalence of Barrett Esophagus or Barrett’s Syndrome among the masses across the world is one of the major factors that is boosting the growth of the global barrett esophagus market. As per the estimates, approximately 1.6% to 6.8% of the total global population suffers from the disease every year till date and this share is projected to escalate over the forecast period. In addition to that, there are also a rising number of patients suffering from GERD which further elevates the risk of Barrett’s esophagus, thereby propelling the growth of the global Barrett's esophagus market in the forthcoming years.

Furthermore, the rising count of surgical interventions and procedures in different disease conditions is also playing a positive role in providing significant growth opportunities for the global Barrett Esophagus market in the coming years.

Rising incidence related to esophageal diseases is major factor driving growth of the global barrett esophagus market across the globe. Also increasing number of patients suffering from gastro esophagus reflux disease (GERD) that increases the risk of barrett’s esophagus will propel growth of the global market over the forecast period. Increasing changes in the lifestyle are leading to increasing consumption of alcohol causing GERD among people and obesity are expected to drive the growth barrett’s esophagus market globally. According to data published by World Health Organization (WHO), in 2018, alcohol consumption leads to 3 Mn deaths each year globally as well as to the disabilities and poor health of millions of people. In addition, 9.6 Mn people worldwide are accounted to die from cancer in 2018. However, the asymptomatic condition of barrett’s esophagus, patent expiry of drugs employed for the treatment of GERD, and the availability of over-the counter drugs are some of the factor which are expected to act as a barrier in the growth of the global barrett esophagus market in the near future. Nevertheless, growing number of surgical procedures and surgical interventions in various disease conditions are expected to create immense growth opportunities for the global postoperative pain management market over the forecast period.

Barrett Esophagus Market Segmentation

Global barrett esophagus market is segmented on the basis of treatment, distribution channel, and by region.

•    By Treatment:

    Medications 

    Proton Pump Inhibitors

    Antacids

    H2 Blockers

    Promotility Agents

    Others

    Surgical Treatment

    Radiofrequency Ablation

    Photodynamic Therapy

    Endoscopic Spray Cryotherapy

    Endoscopic Mucosal Resection

    Surgery

•    By Distribution Channel:

    Hospital Pharmacies

    Retail Pharmacies

    Over The Counter

    Others

•    By Region:

    North America

    Europe

    Asia Pacific

    Latin America

    Middle East

    Africa

Barrett Esophagus Market Drugs Overview

Endoscopy and biopsy are main processes which helps to diagnosed Barrett’s esophagus syndrome. After the diagnosis of disease in patient body, patients are prescribed for proton pump inhibitors in which uptake of acid-suppressing medications is done. Omeprazole, pantoprazole, lansoprazole, esomeprazole, and rabeprazole are some of the various drugs which includes in proton pump inhibitors. Healthcare experts also recommend surgery for the treatment of barrett’s esophagus complication which includes ablative therapies i.e. radiofrequency ablation and photodynamic therapy, and esophagectomy and mucosal resection. Risk of barrett’s esophagus can be avoided with the help of dietary changes with the help of increasing intake of more vegetables, vitamins and fruits in person’s regular meals for the day.

Barrett's esophagus can be classified into three categories:

Source: Drugbank, 2018

Barrett Esophagus Market Competitive Landscape

Some of the key participating players in global barrett esophagus market are Addex Therapeutics, AstraZeneca, Plc., Rottapharm (Meda AB), Takeda Pharmaceutical Company Limited, Eisai Co. Ltd., Pfizer, Inc., Torax Medical, Mederi Therapeutics, Aros Pharma, Torax Medical, Inc., and C. R. Bard.

Regional Segmentation

On the basis of region, the barrett esophagus market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

1.    Global Barrett Esophagus Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Barrett Esophagus Market Overview

2.1.    Introduction

2.1.1.    Market Definition

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Barrett Esophagus Market Snapshot

2.4.    Global Barrett Esophagus Market Size and Forecast, 2019–2027

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2019–2027)

2.5.    Global Barrett Esophagus Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Barrett Esophagus Market, By Treatment

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Treatment

3.1.2.    BPS Analysis, By Treatment

3.2.    Market Revenue (US$Mn) Forecast, By Treatment

3.2.1.    Medications 

3.2.1.1.    Proton Pump Inhibitors

3.2.1.2.    Antacids

3.2.1.3.    H2 Blockers

3.2.1.4.    Promotility Agents

3.2.1.5.    Others

3.2.2.    Surgical Treatment

3.2.2.1.    Radiofrequency Ablation

3.2.2.2.    Photodynamic Therapy

3.2.2.3.    Endoscopic Spray Cryotherapy

3.2.2.4.    Endoscopic Mucosal Resection

3.2.2.5.    Surgery

3.3.    Global Barrett Esophagus Market Attractiveness Index, By Treatment

4.    Global Barrett Esophagus Market, By Distribution Channel

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By Distribution Channel

4.1.2.    BPS Analysis, By Distribution Channel

4.2.    Market Revenue (US$Mn) Forecast, By Distribution Channel

4.2.1.    Hospital Pharmacies

4.2.2.    Retail Pharmacies

4.2.3.    Over The Counter

4.2.4.    Others

5.    Global Barrett Esophagus Market, By Region

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Region

5.1.2.    BPS Analysis, By Region

5.2.    Market Revenue (US$Mn) Forecast, By Region

5.2.1.    North America

5.2.2.    Latin America

5.2.3.    Europe

5.2.4.    Asia Pacific

5.2.5.    Middle East

5.2.6.    Africa

5.3.    Global Barrett Esophagus Market Attractiveness Index, By Region

6.    North America Barrett Esophagus Market Analysis and Forecast, 2019–2027

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Country

6.1.2.    BPS Analysis, By Country

6.2.    Market Revenue (US$Mn) Forecast, By Country

6.2.1.    U.S. Barrett Esophagus Market

6.2.2.    Canada Barrett Esophagus Market

6.3.    North America Barrett Esophagus Market, By Treatment

6.3.1.    Medications 

6.3.1.1.    Proton Pump Inhibitors

6.3.1.2.    Antacids

6.3.1.3.    H2 Blockers

6.3.1.4.    Promotility Agents

6.3.1.5.    Others

6.3.2.    Surgical Treatment

6.3.2.1.    Radiofrequency Ablation

6.3.2.2.    Photodynamic Therapy

6.3.2.3.    Endoscopic Spray Cryotherapy

6.3.2.4.    Endoscopic Mucosal Resection

6.3.2.5.    Surgery

6.4.    North America Barrett Esophagus Market, By Distribution Channel

6.4.1.    Hospital Pharmacies

6.4.2.    Retail Pharmacies

6.4.3.    Over The Counter

6.4.4.    Others

6.5.    North America Barrett Esophagus Market Attractiveness Index

6.5.1.    By Country

6.5.2.    By Distribution Channel

6.5.3.    By Treatment

7.    Latin America Barrett Esophagus Market Analysis and Forecast, 2019–2027

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market (US$Mn) Forecast, By Country

7.2.1.    Brazil Barrett Esophagus Market

7.2.2.    Mexico Barrett Esophagus Market

7.2.3.    Argentina Barrett Esophagus Market

7.2.4.    Rest of Latin America Barrett Esophagus Market

7.3.    Latin America Barrett Esophagus Market, By Treatment

7.3.1.    Medications 

7.3.1.1.    Proton Pump Inhibitors

7.3.1.2.    Antacids

7.3.1.3.    H2 Blockers

7.3.1.4.    Promotility Agents

7.3.1.5.    Others

7.3.2.    Surgical Treatment

7.3.2.1.    Radiofrequency Ablation

7.3.2.2.    Photodynamic Therapy

7.3.2.3.    Endoscopic Spray Cryotherapy

7.3.2.4.    Endoscopic Mucosal Resection

7.3.2.5.    Surgery

7.4.    Latin America Barrett Esophagus Market, By Distribution Channel

7.4.1.    Hospital Pharmacies

7.4.2.    Retail Pharmacies

7.4.3.    Over The Counter

7.4.4.    Others

7.5.    Latin America Barrett Esophagus Market Attractiveness Index

7.5.1.    By Country

7.5.2.    By Distribution Channel

7.5.3.    By Treatment

8.    Europe Barrett Esophagus Market Analysis and Forecast, 2019–2027

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market (US$Mn) Forecast, By Country

8.2.1.    U.K. Barrett Esophagus Market

8.2.2.    Germany Barrett Esophagus Market

8.2.3.    Italy Barrett Esophagus Market

8.2.4.    France Barrett Esophagus Market

8.2.5.    Spain Barrett Esophagus Market

8.2.6.    Russia Barrett Esophagus Market

8.2.7.    Poland Barrett Esophagus Market

8.2.8.    BENELUX Barrett Esophagus Market

8.2.9.    NORDIC Barrett Esophagus Market

8.2.10.    Rest of Europe Barrett Esophagus Market

8.3.    Europe Barrett Esophagus Market, By Treatment

8.3.1.    Medications 

8.3.1.1.    Proton Pump Inhibitors

8.3.1.2.    Antacids

8.3.1.3.    H2 Blockers

8.3.1.4.    Promotility Agents

8.3.1.5.    Others

8.3.2.    Surgical Treatment

8.3.2.1.    Radiofrequency Ablation

8.3.2.2.    Photodynamic Therapy

8.3.2.3.    Endoscopic Spray Cryotherapy

8.3.2.4.    Endoscopic Mucosal Resection

8.3.2.5.    Surgery

8.4.    Europe Barrett Esophagus Market, By Distribution Channel

8.4.1.    Hospital Pharmacies

8.4.2.    Retail Pharmacies

8.4.3.    Over The Counter

8.4.4.    Others

8.5.    Europe Barrett Esophagus Market Attractiveness Index

8.5.1.    By Country

8.5.2.    By Distribution Channel

8.5.3.    By Treatment

9.    Asia Pacific Barrett Esophagus Market Analysis and Forecast, 2019–2027

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    China Barrett Esophagus Market

9.2.2.    India Barrett Esophagus Market

9.2.3.    Japan Barrett Esophagus Market

9.2.4.    Australia and New Zealand Barrett Esophagus Market

9.2.5.    South Korea Barrett Esophagus Market

9.2.6.    ASEAN Barrett Esophagus Market

9.2.7.    Rest of Asia Pacific Barrett Esophagus Market

9.3.    Asia Pacific Barrett Esophagus Market, By Treatment

9.3.1.    Medications 

9.3.1.1.    Proton Pump Inhibitors

9.3.1.2.    Antacids

9.3.1.3.    H2 Blockers

9.3.1.4.    Promotility Agents

9.3.1.5.    Others

9.3.2.    Surgical Treatment

9.3.2.1.    Radiofrequency Ablation

9.3.2.2.    Photodynamic Therapy

9.3.2.3.    Endoscopic Spray Cryotherapy

9.3.2.4.    Endoscopic Mucosal Resection

9.3.2.5.    Surgery

9.4.    Asia Pacific Barrett Esophagus Market, By Distribution Channel

9.4.1.    Hospital Pharmacies

9.4.2.    Retail Pharmacies

9.4.3.    Over The Counter

9.4.4.    Others

9.5.    Asia Pacific Barrett Esophagus Market Attractiveness Index

9.5.1.    By Country

9.5.2.    By Treatment

10.    Middle East Barrett Esophagus Market, By Region

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    GCC Countries Barrett Esophagus Market

10.2.2.    Israel Barrett Esophagus Market

10.2.3.    Oman Barrett Esophagus Market

10.2.4.    Rest of Middle East Barrett Esophagus Market

10.3.    Middle East Barrett Esophagus Market, By Treatment

10.3.1.    Medications 

10.3.1.1.    Proton Pump Inhibitors

10.3.1.2.    Antacids

10.3.1.3.    H2 Blockers

10.3.1.4.    Promotility Agents

10.3.1.5.    Others

10.3.2.    Surgical Treatment

10.3.2.1.    Radiofrequency Ablation

10.3.2.2.    Photodynamic Therapy

10.3.2.3.    Endoscopic Spray Cryotherapy

10.3.2.4.    Endoscopic Mucosal Resection

10.3.2.5.    Surgery

10.4.    Middle East Barrett Esophagus Market, By Distribution Channel

10.4.1.    Hospital Pharmacies

10.4.2.    Retail Pharmacies

10.4.3.    Over The Counter

10.4.4.    Others

10.5.    Middle East Barrett Esophagus Market Attractiveness Index

10.5.1.    By Country

10.5.2.    By Distribution Channel

10.5.3.    By Treatment

11.    Africa Barrett Esophagus Market, By Region

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    South Africa Barrett Esophagus Market

11.2.2.    Egypt Barrett Esophagus Market

11.2.3.    North Africa Barrett Esophagus Market

11.2.4.    Rest of Africa Barrett Esophagus Market

11.3.    Africa Barrett Esophagus Market, By Treatment

11.3.1.    Medications 

11.3.1.1.    Proton Pump Inhibitors

11.3.1.2.    Antacids

11.3.1.3.    H2 Blockers

11.3.1.4.    Promotility Agents

11.3.1.5.    Others

11.3.2.    Surgical Treatment

11.3.2.1.    Radiofrequency Ablation

11.3.2.2.    Photodynamic Therapy

11.3.2.3.    Endoscopic Spray Cryotherapy

11.3.2.4.    Endoscopic Mucosal Resection

11.3.2.5.    Surgery

11.4.    Africa Barrett Esophagus Market, By Distribution Channel

11.4.1.    Hospital Pharmacies

11.4.2.    Retail Pharmacies

11.4.3.    Over The Counter

11.4.4.    Others

11.5.    Africa Barrett Esophagus Market Attractiveness Index

11.5.1.    By Country

11.5.2.    By Distribution Channel

11.5.3.    By Treatment

12.    Recommendation

12.1.    Market Strategy

13.    Competitive Landscape

13.1.    Competition Dashboard

13.2.    List and Company Overview of Global Key Players

13.3.    Company Profiles

13.3.1.    Addex Therapeutics

13.3.1.1.    Company Overview

13.3.1.2.    Financial Overview

13.3.1.3.    Product Portfolio

13.3.1.4.    Key Developments

13.3.1.5.    Business Strategies

13.3.2.    AstraZeneca Plc.

13.3.3.    Rottapharm (Meda AB)

13.3.4.    Takeda Pharmaceutical Company Limited

13.3.5.    Eisai Co. Ltd.

13.3.6.    Pfizer Inc.

13.3.7.    Torax Medical

13.3.8.    Mederi Therapeutics

13.3.9.    Aros Pharma

13.3.10.    Torax Medical, Inc.

13.3.11.    C. R. Bard

14.    Acronyms